Indeed, in a separate experiment transgenic mice treated with the 2 2,4-pyrimidinediamine for 25 days were examined 3 months after cessation of drug administration
Indeed, in a separate experiment transgenic mice treated with the 2 2,4-pyrimidinediamine for 25 days were examined 3 months after cessation of drug administration. together reinforce the pivotal role of EML4-ALK in the pathogenesis of NSCLC in humans, and they…